Molly Zielen
Medical · Camp Hill, PANPI 1255700845
Payments from drug & device makers
Across 279 payments — averaging $14.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$686
- GSK$392
- Amgen$305
- Novo Nordisk$287
- Lilly USA, LLC$236
- AstraZeneca$232
- plus $2K from 25 others
What the payments were for
- Food & beverage$4,02099%
- Education$301%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 48 | $686 |
| GSK | 41 | $392 |
| Amgen | 19 | $305 |
| Novo Nordisk | 27 | $287 |
| Lilly USA, LLC | 17 | $236 |
| AstraZeneca | 13 | $232 |
| Amarin Pharma, Inc. | 15 | $224 |
| Biohaven Pharmaceuticals, Inc. | 7 | $141 |
| Novartis | 8 | $124 |
| Boehringer Ingelheim | 7 | $113 |
| Pfizer | 7 | $112 |
| Dexcom, Inc. | 6 | $110 |
| Teva Pharmaceuticals USA, Inc. | 6 | $103 |
| Merck | 7 | $102 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $91 |
| Johnson & Johnson | 5 | $88 |
| Daiichi Sankyo Inc. | 4 | $84 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $83 |
| E.r. Squibb & Sons, L.L.C. | 5 | $79 |
| Bayer | 4 | $78 |
| Kowa Pharmaceuticals America, Inc. | 5 | $72 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $52 |
| Scilex Pharmaceuticals Inc. | 3 | $51 |
| Almatica Pharma LLC | 3 | $43 |
| Astellas Pharma US Inc | 2 | $40 |
| OPKO Pharmaceuticals, LLC | 2 | $30 |
| Bausch Health US, LLC | 1 | $24 |
| Esperion Therapeutics, Inc. | 2 | $24 |
| Urovant Sciences Inc | 1 | $20 |
| Nestle Healthcare Nutrition Inc. | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $11 |
How this compares
$4,050 in reported general payments places this provider in the 85th percentile of 2,594 medical providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Alendronate Sodium | 13 | $242 |
| Sertraline Hcl | 13 | $171 |
| Meloxicam | 13 | $130 |
| Levothyroxine Sodium | 13 | $115 |
| Simvastatin | 13 | $68 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Almatica Pharma LLCSertraline Hcl | $43 | $17113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,594 medical providers in Pennsylvania.
Other medical in Camp Hill
- Jacqueline KernaghanSpringfield$427K
- Drew SodaNew Hope$220K
- Angela KapalkoPhiladelphia$123K
- Linda PerryPhiladelphia$123K
- Cory DavidsonErie$119K
- Shelley SassamanTamaqua$90K
- Meghan HoffnerBethlehem$86K
- Thomas IacovoniDanville$72K
- Scott CoxWynnewood$66K
- Sarah SmithPhiladelphia$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.